Cassava Sciences is nearing a Phase 3 readout for its Alzheimer's drug, lecanemab, despite facing a scandal involving the SEC. Learn more about the latest updates on donanemab and the company's ...

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate ...

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end. The company has reported top-line data from a second phase 3 trial of the drug, which ...

Cassava Sciences Shares Lower Premarket on $40 Million Penalty to Settle Doctored Data Claims Global News Select Sep 27, 2024, 3:48:00 AM ...

However, there are also non-viral types of hepatitis. Hepatitis can cause liver damage, making it difficult for your liver to function as it should. Most types of viral hepatitis are contagious.

View the most recent data and latest information on option chains for Cassava Sciences, Inc. Common Stock (SAVA) at Nasdaq.com.

The BioAdvanced 701100A contains 0.22% Imidacloprid that provides excellent protection against mealybugs, as well as other listed pests, for up to 12 months. The beauty of this insecticide is it kills ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

The latest International Space Stationbreaking news, comment, reviews and features from the experts at ...